Latest News in the pharma Industry

Policy & Regulation

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha (Evolocumab)

European Commission Approves Amgen's New Cholesterol-Lowering Medication Repatha (Evolocumab)

21 Jul 2015

Read more 
Rx-360 Summary: Israel and Brazil API Standards Are Equivalent to EU

Rx-360 Summary: Israel and Brazil API Standards Are Equivalent to EU

20 Jul 2015

Read more 
European Commission Approves BMS’s Evotaz (Atazanavir and Cobicistat Fixed-Dose Combination) for the Treatment of HIV-1 Infection in Adults

European Commission Approves BMS’s Evotaz (Atazanavir and Cobicistat Fixed-Dose Combination) for the Treatment of HIV-1 Infection in Adults

17 Jul 2015

Read more 
World Courier Receives Wholesale Distribution Authorisation

World Courier Receives Wholesale Distribution Authorisation

16 Jul 2015

Read more 
Rx-360 Summary ICH Q7 Guideline: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients Q&A

Rx-360 Summary ICH Q7 Guideline: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients Q&A

15 Jul 2015

Read more 
EMA to Further Clarify Safety Profile of Human Papillomavirus Vaccines

EMA to Further Clarify Safety Profile of Human Papillomavirus Vaccines

14 Jul 2015

Read more 
FDA Approves Iressa for First-Line Treatment of Patients with a Type of Metastatic Lung Cancer

FDA Approves Iressa for First-Line Treatment of Patients with a Type of Metastatic Lung Cancer

14 Jul 2015

Read more 
FDA Approves New Drug to Treat Schizophrenia and as an Add-On to an Antidepressant to Treat Major Depressive Disorder?

FDA Approves New Drug to Treat Schizophrenia and as an Add-On to an Antidepressant to Treat Major Depressive Disorder?

13 Jul 2015

Read more 
Rx-360 Summary of Q&A on WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce

Rx-360 Summary of Q&A on WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce

13 Jul 2015

Read more 
Lilly Statement on FDA Advisory Committee Review of Necitumumab

Lilly Statement on FDA Advisory Committee Review of Necitumumab

9 Jul 2015

Read more 
FDA Strengthens Warning that Non-Aspirin NSAIDs Can Cause Heart Attacks or Strokes

FDA Strengthens Warning that Non-Aspirin NSAIDs Can Cause Heart Attacks or Strokes

9 Jul 2015

Read more 
Novartis' New Heart Failure Medicine, Entresto, Approved by FDA to Reduce Risk of Cardiovascular Death and heart failure

Novartis' New Heart Failure Medicine, Entresto, Approved by FDA to Reduce Risk of Cardiovascular Death and heart failure

8 Jul 2015

Read more